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Subchronic exposure to pharmacological levels of estrogenic compounds, including 1713-estradiol, diethylstil-
bestrol, and a-dienestrol, significantly increased the mortality of B6C3F, female mice after Listeria infection.
Compounds with little estrogenic activity, including 5a-dihydrotestosterone, progesterone, zearalenol, and
corticosterone, did not alter Listeria-related mortality. Estrogen-induced alterations in resistance were
inhibited by both adult thymectomy and the estrogen antagonist tamoxifen. Estrogen exposure depressed the
accumulation of monocytes and lymphocytes at infective foci. Significantly elevated numbers of bacteria were
observed in infective foci of estrogen-treated mice later in the infection when bacteria were nearly eliminated
from untreated animals. These results indicate that estrogen-induced suppression of Listeria immunity is
partially mediated by the thymus, probably through receptor events which may ultimately suppress the
activation of T cell-dependent defense mechanisms. This may be partially reflected by the inability of estrogen-
exposed mice to eliminate Listeria cells or to accumulate mononuclear effector cells at infective foci at the same
rate as controls.
Pharmacological (i.e., therapeutic) levels of estrogen alter
resistance to a variety of infections in laboratory animals.
For example, estrogen-treated mice are less susceptible than
controls to bacteria such as Pneumococcus type I, Pasteu-
rella spp., and Salmonella spp. (30). Mice exposed to
diethylstilbestrol (DES) are more resistant to the formation
of transplantable lung melanoma tumors (8, 29), and estro-
gens may also lessen the severity of certain plasmodial,
babesial, and trypanosomal infections (2, 17, 26). Paradoxi-
cally, exposure to pharmacological levels of estrogen pro-
foundly decreases host resistance to a variety of other
infectious agents. Illustrative of this are the findings that
DES exposure precipitates a dramatic increase in Listeria
susceptibility, impairs the intestinal expulsion of adult Tri-
chinella sp., and increases the susceptibility of mice to both
viral and methylcholanthrene-induced tumors (4, 15). 1713-
Estradiol induces more intense chlamydial (36) and staphylo-
coccal (47) infections, whereas hexestrol administration in-
creases the severity of experimental toxoplasmosis in mice
(18).
The divergent effects of estrogens on resistance may, in
some instances, be due to the quantity of chemical injected
(8) or the route of infection (29). In addition, it is likely that
altered host resistance correlates with immune function
disturbances caused by estrogenic compounds. For exam-
ple, estrogens are potent stimulants of the mononuclear
phagocyte system (1, 22, 31, 49) but suppress natural killer
cell activity (14, 41) and T cell-mediated immunity as well
(12, 13, 23). Estrogens may induce these alterations by
affecting the production of immunoregulatory thymic hor-
mones (9, 24, 42). Increased resistance to certain organisms
is often attributed to estrogen-related enhancement of mac-
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rophage activity (2, 17, 29, 30). Conversely, estrogen-in-
duced defects in natural killer cell functions and T-cell
responses may decrease resistance to other infectious agents
(4, 15, 18).
The aim of the present study was to systematically exam-
ine the mechanisms associated with the increased suscepti-
bility to Listeria monocytogenes infection which occurs after
exposure to pharmacological levels of estrogen. The rela-
tionship between altered host resistance and the estrogenic-
ity (i.e., uterotrophic activity) of sex hormones was deter-
mined by investigating the effect of a variety of steroidal and
nonsteroidal compounds, with a range of estrogenic activi-
ties, on host resistance to L. monocytogenes. The role of the
thymus and the operational estrogen receptor was studied by
investigating the effects of adult thymectomy (TX) and the
estrogen antagonist tamoxifen on Listeria resistance after
estrogen exposure. In addition, studies were designed to
determine the nature of the immune disturbances induced by
estrogens which are responsible for the alterations in host
resistance.
MATERIALS AND METHODS
Mice. Specific-pathogen-free B6C3Fj (C57BL6 x C3H/
He) female mice (6 to 8 weeks old) were obtained from
National Cancer Institute production contracts (Charles
River, Portage, Mich.). Animals weighed an average of ca.
20 g at the time of the studies, were maintained on a 12-h
light-dark cycle at 68 to 73°F, and were provided with sterile
food (Ziegler Bros., Inc., Gardner, Pa.) and water ad libi-
tum. Thymectomies and ovariectomies were performed un-
der pentobarbital anesthesia.
Dosing regimen. DES, 17p-estradiol, 5a-dihydrotestoster-
one (5a-DHT), a-dienestrol, and progesterone were ob-
tained from Sigma Chemical Co. (St. Louis, Mo.). Corticos-
terone was obtained from Calbiochem-Behring (La Jolla,
Calif.). Zearalenol was generously provided by M. Bachman
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of International Minerals and Chemical Corp. (Terre Haut,
Ind.). 1-Dienestrol was kindly donated by M. Metzler,
University of Warzburg, Warzburg, Federal Republic of
Germany. All chemicals except zearalenol and corticoste-
rone were dissolved in corn oil with gentle heating. Zeara-
lenol was dissolved in ethanol and mixed with corn oil after
which alcohol was evaporated by blowing gaseous nitrogen
over the mixture. Corticosterone was injected as a well-
mixed suspension in corn oil. Chemical concentrations were
prepared on a milligram per kilogram of body weight basis.
Mice were treated with 2.8 ,umol or less of chemical to
minimize possible toxic or nonhormonal effects. Mice were
injected subcutaneously in the dorsal cervical region with
the desired concentration of chemical in 0.1 ml of corn oil for
5 consecutive days. Control mice received corn oil only
(vehicle control). Studies were begun 3 to 5 days after the
last treatment dose. In studies in which estrogen antagonists
were examined, mice were dosed subcutaneously with 1.2
Fmol of tamoxifen citrate (a gift of D. H. McCurdy, Stuart
Pharmaceuticals, Wilmington, Del.) in saline daily for 3
days. On days 2 and 3 they also received 1.2 ,umol of
estradiol. Controls received saline and corn oil (vehicle
control). In all cases, reported doses reflect the total amount
of chemical injected.
Listeria susceptibility. A frozen stock of L. monocytogenes
(strain L242/73 type 4B) from a naturally infected mouse was
used throughout this study. Bacteria were grown overnight
at 37°C in brain heart infusion broth. The number of bacteria
in the broth was quantitated turbidimetrically in a spectro-
photometer (Gilford Instrument Laboratories, Inc., Oberlin,
Ohio) at 540 nm and confirmed by plate counts. The desired
concentration of bacteria was prepared by diluting the stock
in cold Hanks balanced salt solution. Organisms were inject-
ed into mice intravenously (i.v.) in a volume of 0.2 ml 4 to 5
days after estrogen exposure. For survival studies mice were
inoculated with ca. 5 x 104 viable Listeria cells (20% lethal
dose) and monitored for 14 days or until death. Bacterial
enumeration in spleens and livers was conducted after a
nonlethal i.v. infection (104 organisms) as described previ-
ously (48). Briefly, a tissue grinder was used to homogenize
organs in distilled water plus 0.05% Triton X-100 (New
England Nuclear Corp., Boston, Mass.). Homogenates were
serially diluted and plated on brain heart infusion agar plates.
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FIG. 1. Effect of DES and 17p-estradiol exposure on survival of
B6C3F, female mice after Listeria infection. Each point represents a
minimum of 10 animals. Significantly increased mortality (P < 0.05)
occurred in mice treated with more than 0.04 ,umol of DES or
estradiol.
TABLE 1. Susceptibility to Listeria cells after exposure to
compounds with various estrogenic activities"
Treatmentb No. dead/ % Mortalityno. tested









a Data represent a summation of several experiments in which vehicle-and
DES-or estradiol-exposed mice were used as controls. Listeria-related mortal-
ity increased significantly as a result of exposure to either DES or estradiol in
each experiment. The mortality range averaged from 20 to 25% for each
group.
b Mice received a total dose of 2.8 ,umol of chemical (which equals 40 mg of
estradiol per kg of body weight).
c Significantly different from vehicle controls at P < 0.05.
macrophages and to break up clumps of bacteria. Duplicate
plates were prepared for all samples at each dilution. Report-
ed Listeria titers represent mean values obtained from six
individual mice per group.
In vivo listericidal assay. Mice were injected intraperitone-
ally (i.p.) with 5 x 105 Listeria in 0.5 ml of Hanks balanced
salt solution. At indicated times after infection, bacteria
were obtained from the peritoneal cavity by lavage with 5 ml
of Hanks balanced salt solution. Serial dilutions in Hanks
balanced salt solution plus 0.05% Triton X-100 were pre-
pared and plated in duplicate on brain heart infusion agar to
determine the number of viable Listeria cells. Cytocentri-
fuge preparations of peritoneal exudate cells were stained
with Diff-Quik (American Scientific Products, McGaw Park,
Ill.) and used to calculate differential cell counts. The total
number of peritoneal exudate cells was determined with a
Coulter Counter (model ZB; Coulter Electronics, Inc., Hia-
leah, Fla.). Reported Listeria titers and peritoneal exudate
cell numbers represent mean values obtained from five
individual mice per group.
PYB6 tumors. A polyoma virus-induced tumor developed
in C57BL6 mice (PYB6) was obtained from Jack Dean
(Chemical Industry Institute of Toxicology, Research Trian-
gle Park, N.C.) and maintained by passage through syngene-
ic B6C3F, female mice. For experimental studies, mice were
inoculated subcutaneously in the right rear flank with 3 x 103
viable tumor cells (10 to 20% tumor dose) suspended in
RPMI 1640 medium containing 25 mM HEPES (N-2-hy-
droxyethylpiperazine-N'-2-ethanesulfonic acid) buffer plus
10% fetal calf serum (GIBCO Laboratories, Grand Island,
N.Y.) 4 to 5 days after estrogen exposure. Animals were
palpated weekly for 60 days, and tumor frequency, size, and
latency were recorded.
Statistical analysis. The chi-square test was used to assess
the significance of treatment effects in mortality studies.
Student's t test was used to compare results obtained from
experimental groups in all other instances.
RESULTS
The administration of either estradiol or DES resulted in a
marked increase in the susceptibility offemale B6C3F1 mice
to L. monocytogenes. Significantly increased mortality after
Listeria infection occurred in mice treated with greater than
0.04 ,umol of DES or estradiol (Fig. 1). Time to death
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decreased from 7 days in control mice to ca. 5 days (P <
0.001) in mice exposed to 2.8 ,umol of either compound (data
not shown). Table 1 summarizes the results obtained after
exposure of mice to equimolar concentrations (2.8 ,umol) of
various hormonally active compounds before Listeria infec-
tion. DES, estradiol, and a-dienestrol, which display rela-
tively high estrogenic activity, caused a significant increase
in mortality. Compounds such as 5a-DHT, progesterone,
zearalenol, and P-dienestrol, which have little or no estro-
genic activity, did not increase mortality. Corticosterone
was also found to have no effect on Listeria resistance at this
dose level.
To determine if increased Listeria susceptibility after
estrogen treatment was due to an ovarian dysfunction in-
duced by estrogen treatment, adult mice were ovariecto-
mized and exposed to estradiol before Listeria infection.
Ovariectomy did not influence the effects of exposure to
pharmacological levels of estrogen on resistance as both
sham-operated and ovariectomized mice were equally sus-
ceptible to L. monocytogenes after estradiol treatment (Ta-
ble 2).
The influence of antiestrogens on host resistance was
examined by simultaneously administering estradiol and
tamoxifen, a nonsteroidal estrogen antagonist. The increase
in host susceptibility due to estradiol was prevented by
tamoxifen treatment (Table 3). Listeria-related mortality in
mice dosed with tamoxifen plus estradiol was similar to that
of vehicle controls. Exposure to tamoxifen alone did not
affect survival.
Since it has been proposed that estrogens influence im-
mune functions by altering thymic hormone levels (9, 24,
42), we examined the effect of surgical thymectomy (TX) on
estrogen-induced alterations in host resistance. In these
studies, adult female mice were thymectomized and treated
with estradiol before L. monocytogenes infection. TX af-
forded protection against estrogen-altered host resistance
after low-dose estrogen administration (Table 4). Listeria-
related mortality in thymectomized mice dosed with 0.04
,umol of estradiol was similar to that observed in vehicle
controls. On the other hand, estradiol-exposed sham-operat-
ed mice had significantly higher mortality than did controls.
The protective effect of TX on Listeria resistance was not
observed in mice treated with a greater dose of estradiol
(0.74 ,umol), which suggests that at higher exposure levels,
nonthymic mechanisms may be involved. Intermediate dos-
age levels were not examined. A similar experiment was
performed with transplantable tumor cell inoculation rather
than Listeria infection to reconfirm that the thymus plays a
role in estrogen-induced alterations of host resistance (Table
4). TX protected mice against the effects of estrogen on
syngeneic tumor formation. Tumor incidence in both DES-
exposed and control thymectomized mice was 50%. Tumor
incidence in sham-operated mice treated with DES (90%)
was significantly higher than in controls.
TABLE 2. Effects of 17p-estradiol on susceptibility to Listeria
cells after adult ovariectomy (OVX)
Total dose of Intact (sham) OVX
estradiol No. dead! No. dead!
(>mol) no. tested % Mortality no. tested % Mortality
0 (vehicle) 2/13 15 4/13 31
0.04 6/14 43 5/14 36
0.40 8/14 57a 11/14 78a
a Significantly different from vehicle controls at P < 0.05.
TABLE 3. Susceptibility to Listeria cells after exposure to
estradiol and tamoxifen




Tamoxifen + estradiol 2/15 13
a Mice were dosed with a total of 3.6 ,umol of tamoxifen or 2.4 ,umol of
estradiol or both.
b Significantly different from vehicle controls at P < 0.05.
The growth kinetics of L. monocytogenes in the spleens of
estrogen-treated mice was determined by monitoring splenic
bacterial growth over a 7-day period after i.v. inoculation
with a sublethal dose of L. monocytogenes (Fig. 2). One day
after infection no differences were observed between the
numbers of Listeria cells in the spleens of control and
estrogen-treated mice. However, there were significantly
higher numbers of bacteria in the spleens of both DES and
estradiol-treated mice when compared with control mice on
days 4 and 7 after infection. Estrogen exposure had the same
effect on Listeria titers in the livers of i.v.-infected mice and
the spleens of i.p.-infected mice (data not shown).
To examine the effect of estrogen exposure on leukocyte
accumulation at infective foci, we determined the number of
peritoneal lymphocytes, monocytes, and polymorphonucle-
ar leukocytes (PMNs) after an i.p. injection of viable Listeria
cells. At the same time the peritoneal growth kinetics of the
bacteria were monitored. Estrogen exposure depressed the
accumulation of lymphocytes and monocytes in the perito-
neal cavities of i.p.-infected mice (Fig. 3). The number of
peritoneal lymphocytes and monocytes was greater in mice
exposed to DES than in vehicle controls on the day of
infection. However, the quantity of lymphocytes rose to
significantly higher levels in the controls by day 4 after
infection and remained elevated above peritoneal lympho-
cyte numbers in the DES-treated mice through day 5. The
number of peritoneal monocytes increased to significantly
higher levels in the controls than in the DES-treated mice on
days 3 and 4 after infection. Comparable quantities of
monocytes were not observed in the DES-exposed animals
until day 5. DES treatment augmented rather than delayed
the accumulation of PMNs in the peritoneal cavities of i.p.-
infected mice. Peritoneal accumulation of PMNs rose to
peak levels on day 2 in the controls and then declined. The
number of PMNs in the peritoneal cavities of the DES-
treated mice had risen to significantly higher levels than
observed in the controls by day 3 and remained significantly
elevated on days 4 and 5.
TABLE 4. Effect of estrogen on susceptibility to Listeria and
PYB6 tumor cells after adult TX
Total dose of No. dead/no, tested (%) with Tetd( ithPdence/noB
estrogenL tumor cells
(jimol) Intact Intact
(sham) TX (sham) TX
O (vehicle) 4/19 (21) 7/27 (26) 4/10 (40) 5/10 (50)
0.04 13/15 (87)b 11/29 (38) NDc ND
0.74 20/24 (75)b 18/24 (75)b 9/10 (90)b 5/10 (50)
a Mice were treated with estradiol in the Listeria studies and with DES in
the tumor study.
b Significantly different from vehicle controls at P < 0.05.
c ND, Not done.
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FIG. 2. Growth of Listeria cells in the spleens of mice treated
with vehicle, 2.8 ,umol of DES, or 2.8 ,p.mol of estradiol. Each point
represents the mean value + 1 standard error from six mice. *,
Significantly different from vehicle controls at P K 0.05.
There was a slight, though significant, increase in the
number of bacteria in the peritoneal cavities of the DES-
treated animals 1 day after i.p. infection (Fig. 4). On subse-
quent days the number of bacteria remained lower in the
control mice than in the DES-exposed mice and declined to
essentially nonexistent quantities in the controls by day 5.
The number of bacteria in the DES-treated mice, on the
other hand, remained ca. 3 logs higher than in the controls
from day 3 through day 5. We did not observe measurable
quantities of Listeria cells in the peritoneal cavities of either
vehicle- or DES-treated mice after i.v. infection.
DISCUSSION
These studies demonstrate that pharmacological (i.e.,
therapeutic) levels of steroidal and nonsteroidal estrogens
profoundly alter the susceptibility of mice to L. monocyto-
genes infection. The ability of estrogenic compounds to alter
host resistance to Listeria cells appears to correlate with
their estrogenicity. The classical measure of estrogenic
activity, uterine growth, is initiated after hormone binding to
cytoplasmic receptors and subsequent translocation of the
hormone-receptor complex into the nucleus where binding
to the nuclear chromatin occurs (10, 20). DES and 1713-
estradiol have similar in vitro uterotrophic potency and
binding activity although DES is more potent than estradiol
in vivo (19). DES, 17,3-estradiol, and ct-dienestrol possess in
common a phenolic ring structure in the A-ring region of the
molecule which is believed to be responsible for specific
binding to estrogen receptors (6). Administration of pharma-
cological levels of these compounds caused increased mor-
tality after Listeria infection. Increased mortality also oc-
curred in estrogen-treated ovariectomized mice; thus, the
effects of estrogenic compounds on Listeria resistance are
not indirectly mediated through ovarian dysfunction. Steroi-
dal and nonsteroidal compounds possessing little or no
estrogenic activity did not alter Listeria resistance. These
compounds included progesterone, 5o±-DHT, ,B-dienestrol,
and zearalenol. 3-Dienestrol, although not estrogenic, is a
potent genotoxic metabolite of DES capable of binding to
macromolecules and potentially a direct carcinogen (37). 5ox-
DHT is a hormonally active metabolite of testosterone which
demonstrates slight uterine binding activity but only at
relatively high doses (40). Zearalenol possesses 20% of the
receptor-binding activity of estradiol and only 1% of its
uterotrophic activity (16), suggesting that binding alone will
not induce altered resistance. Exposure to 2.8 pmol of
corticosterone also had no effect on Listeria-related mortal-
ity. Cortisone acetate has been reported to affect Listeria
resistance, but at dosage levels higher than used in our
experiments (34, 39). In contrast, exposure to as little as 0.04
[imol of DES or estradiol significantly increased mortality.
A direct relationship between estrogenic activity and
increased susceptibility to L. monocytogenes was also evi-
denced in studies with the estrogen antagonist tamoxifen.
This compound is a nonsteroidal derivative of triphenyleth-
ylene, has only limited estrogenic activity, and putatively
acts as an antiestrogen by inhibiting the replenishment of
cytoplasmic estrogen receptors (43). We observed that the
effects of estradiol on Listeria resistance are blocked by
concurrent administration of tamoxifen. This further sup-
ports the idea that estrogen-induced modifications of Lis-
teria resistance are, at least in part, due to estrogenic activity
and thus mediated through an operational receptor-like
mechanism similar to the cytosolic estrogen receptor in-
volved in uterotrophic responses.
The reported immunological effects associated with the
administration of estradiol and DES to rodents include
thymic atrophy (5), myelotoxicity (1, 7), stimulation of the
mononuclear phagocyte system (1, 22, 31, 49), suppression
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DAYS AFTER INFECTION
FIG. 3. Number of peritoneal lymphocytes, monocytes, and
PMNs (x 106) in vehicle control and DES (2.8 ,Lmol)-treated mice
after i.p. Listeria infection. Each point represents the mean value ±
1 standard error from five mice. *, Significantly different from
vehicle controls at P < 0.05.
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sion of natural killer cell activity (14, 41). The mechanisms
responsible for the wide range of effects of estrogens on
immunological responses are not well understood, although
increasing evidence suggests that estrogen-dependent im-
munotoxicity is, in part, mediated through the thymus. For
example, experimental evidence suggests that the binding of
estrogen to specific cytosolic receptors in thymic epithelial
cells influences the quality and quantity of thymic hormones
(9, 24, 42). That this may represent a negative regulatory
function was suggested in studies in which surgical TX was
found to protect against estrogen-induced immunosuppres-
sion (24). In the present study, we observed that TX was
protective against estrogen-induced increased susceptibility
to L. monocytogenes. Thus, certain of the effects of estro-
gens on host resistance are related to alterations in thymic
immunoregulation. We noted, however, that when the expo-
sure level of estradiol was increased, the protective effect of
TX was lost. These findings may be reflective of a dual mode
of action of estrogens: one which is mediated by the thymus
at low-dosage levels and a second which directly affects
immune functions at high-dosage levels. This is consistent
with the proposed mechanisms responsible for changes in
immune function by estrogens (M. I. Luster, R. W. Pfeifer,
and A. N. Tucker, in J. Dean, A. E. Munson, M. I. Luster,
and H. Amos [ed.], Target Organ Toxicity, in press).
In a similar experiment, transplantable syngeneic tumor
cell growth was used as the infectivity model. The resistance
of mice to syngeneic tumor cells is primarily dependent on
macrophage- and T cell-mediated immunity (45) and has
been previously shown by us to be decreased by estrogen
exposure (4). In the present study, we demonstrated that the
effects of estrogen on resistance to syngeneic tumor cells
could be inhibited by adult TX. This further confirms that
the thymus plays a role in estrogen-induced modulation of
host resistance.
The ability of mice to resist Listeria infection primarily
depends on the cell-mediated immune response. Recovery is
thought to require T-cell activation of the bactericidal prop-
erties of macrophages (21, 25, 35) and the accumulation of
large numbers of macrophages at infective foci (28, 33, 34,
38). Since estrogen exposure clearly alters macrophage and
T-cell functions, experiments were performed to determine
the role of these alterations on the ensuing Listeria infection.
DAYS AFTER INTRAPERITONEAL INFECTION
FIG. 4. Growth of Listeria cells in the peritoneal cavities of
vehicle control and DES (2.8 ,umol)-treated mice after i.p. infection.
Each point represents the mean value + 1 standard error from five
mice. *, Significantly different from vehicle controls at P < 0.05.
The effects of estrogens on T cells are multifold. For
example, estrogen exposure induces thymic involution (1, 5)
and depresses delayed hypersensitivity as well as lympho-
proliferative responses to allogeneic leukocytes and T-cell
mitogens (13, 23). Estrogens may also depress interleukin-2
production (11). Indirect evidence that estrogens disrupt the
T cell-mediated immune response to Listeria cells was
provided by following the growth of bacteria in the spleens
of estrogen-exposed animals. Substances which are directly
toxic to macrophages are presumably evidenced by greater
than normal numbers of bacteria in the liver and spleen as
early as 24 h after infection. T cell-mediated defects, on the
other hand, are evidenced by greater than normal numbers
of bacteria in these organs only later in the infection, when
complete elimination of the bacteria is thought to be depen-
dent on T cell-dependent events such as macrophage activa-
tion (48). As was shown in this study and suggested by
preceding studies in this laboratory (4), the number of
bacteria in the spleens of estrogen-treated mice was greater
than in control mice only later in the infection. This may
indicate that the ability of nonimmune macrophages to ingest
and destroy Listeria cells is not affected by estrogen expo-
sure but that the disruptive effects of estrogens on Listeria
resistance are related to altered T-cell functions.
The known effects of estrogen exposure on the mononu-
clear phagocyte system include augmented antigen clearance
by the liver (22, 31) and increased peritoneal macrophage
activity (1). Peritoneal macrophages from estrogen-treated
mice do not appear to be fully activated but possess certain
characteristics of inflammatory macrophages. They are hy-
perphagocytic, inhibit tumor cell growth in vitro, and secrete
increased quantities of plasminogen activator (1; J. H. Dean,
M, I. Luster, B. Adkins, L. D. Lauer, and D. 0. Adams, in
A. Volkman [ed.], Mononuclear Phagocyte Biology, in
press). Their bactericidal properties are unknown. We ob-
served that the number of bacteria in the peritoneal cavities
of DES-treated mice was only slightly elevated above that of
the control mice 24 h after an i.p. infection, despite similar
numbers of peritoneal macrophages in both control and
treated mice at that time. Similarly, there was no difference
between splenic titers of Listeria cells in either group 24 h
after an i.v. infection. This may indicate that the ability of
nonimmune macrophages to kill Listeria cells is neither
augmented nor depressed by estrogen exposure. We are
presently investigating this possibility by studying the in
vitro bactericidal properties of these cells. An estrogen-
induced enhancement of the early in vivo bactericidal capac-
ity of fixed liver macrophages has been reported (29).
However, estrogen exposure may increase the number of
liver macrophages as well as their activity (50). Thus,
augmented early destruction of Listeria cells in the livers of
estrogen-exposed mice could be due to increased macro-
phage numbers rather than, or in addition to, an enhance-
ment of the bactericidal capacity of individual cells.
Later in the infection, when macrophage accumulation
and activation are thought be be responsible for elimination
of the bacteria (25, 28, 33, 34), Listeria titers in infective foci
of DES-exposed mice were greatly elevated above control
levels. The fulminant growth of Listeria cells which occurred
in the peritoneal cavities of DES-exposed mice after an i.p.
infection was accompanied by a delay in the accumulation of
macrophages and lymphocytes at the site of infection. The
inability of DES-exposed mice to increase the number of
macrophages in infective foci at the same rate as controls
may account for the virtually unrestricted growth of the
bacteria in these animals. The delay in mononuclear cell
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accumulation could be due to a variety of different factors.
One possible explanation relates to the known effects of
estrogens on lymphokine production. Estrogen exposure
reportedly decreases interleukin-2 production (11). This
might indirectly affect macrophage accumulation at infective
foci by depressing the proliferation of T cells responsible for
the production of other lymphokines including macrophage
chemotactic factor and migration inhibition factor.
Estrogens do not reduce PMN migration into infective
foci. Large numbers of PMNs can be observed in the
peritoneal cavities of DES-exposed mice up to 5 days after
an i.p. infection. Multiplication of bacteria was virtually
unrestricted in the estrogen-exposed mice despite the quanti-
ty of PMNs present in these animals. Although this may
confirm earlier reports'that PMNs play little role in Listeria
resistance in mice (34, 44), there is now evidence that they
can kill Listeria cells in vitro (3). Consequently, an estrogen-
induced defect in the ability of these cells to destroy the
bacteria cannot be ruled out. There is no obvious explana-
tion for sustained PMN accumulation at infective foci after
DES exposure. Other anti-inflammatory agents, most nota-
bly the glucocorticosteroids, may induce similar effects.
Cortisone acetate, for example, augments PMN accumula-
tion in the livers of Listeria-infected mice (34). Dexametha-
sone enhances PMN migration in vitro but has the opposite
effect on macrophages (46).
In summary, estrogen-induced suppression of Listeria
immunity may be mediated by an operational hormone
receptor mechanism and is partially regulated through the
thymus. The effects of estrogen on host defenses include a
depression in the ability of exposed mice to accumulate
monocytes and lymphocytes or eliminate bacteria at infec-
tive foci.'These effects may be related to an estrogen-
induced suppression of the T cell-dependent immune re-
sponse. These findings are of relevance in view of the fact
that estrogenic compounds such as DES and estradiol are
commonly used for both therapeutic and agricultural pur-
poses (27, 32). Clinical observations have provided evidence
that the therapeutic use of estrogens can induce
immunotoxicity (Luster et al., in Dean'et al. (ed.), Target
Organ Toxicity, in press), and the apparent ability of these
compounds to affect susceptibility to infectious diseases
should be considered an additional health hazard.
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